- Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and Combination Therapy
Monika Gosecka et al, 2024, ACS Applied Materials & Interfaces CrossRef - Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer
Xiangping Lin et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer
Soumi Mukherjee et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model
Karan Mediratta et al, 2024, Frontiers in Immunology CrossRef - CREB3 facilitates Donafenib resistance in hepatocellular carcinoma cells via the LSD1/CoREST/p65 axis by transcriptionally activating long noncoding RNA ZFAS1
Xunbo Hou et al, 2024, Translational Oncology CrossRef - Piplartine eliminates CD34 + AML stem/progenitor cells by inducing oxidative stress and suppressing NF-κB signalling
Ana Carolina B. da C. Rodrigues et al, 2024, Cell Death Discovery CrossRef - Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma
K.L. Adeleye et al, 2024, Journal of Dental Research CrossRef - Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling
Peter Kubatka et al, 2024, Cancer and Metastasis Reviews CrossRef - Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells
Yamila Sanchez et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef - Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
J. Nicolás-Morala et al, 2024, Scientific Reports CrossRef